101 related articles for article (PubMed ID: 8315600)
1. Role of cations and IgA in saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis patients.
Armstrong EA; Ziola B; Habbick BF; Komiyama K
J Oral Pathol Med; 1993 May; 22(5):207-13. PubMed ID: 8315600
[TBL] [Abstract][Full Text] [Related]
2. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
3. The role of saliva in aggregation and adherence of Pseudomonas aeruginosa in patients with cystic fibrosis.
Tumber-Saini SK; Habbick BF; Oles AM; Schaefer JP; Komiyama K
J Oral Pathol Med; 1992 Aug; 21(7):299-304. PubMed ID: 1522530
[TBL] [Abstract][Full Text] [Related]
4. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
[TBL] [Abstract][Full Text] [Related]
5. Whole, submandibular, and parotid saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis.
Komiyama K; Habbick BF; Tumber SK
Infect Immun; 1989 Apr; 57(4):1299-304. PubMed ID: 2494114
[TBL] [Abstract][Full Text] [Related]
6. Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Komiyama K; Habbick BF; Tumber SK
Infect Immun; 1987 Oct; 55(10):2364-9. PubMed ID: 3115896
[TBL] [Abstract][Full Text] [Related]
7. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
Carnoy C; Ramphal R; Scharfman A; Lo-Guidice JM; Houdret N; Klein A; Galabert C; Lamblin G; Roussel P
Am J Respir Cell Mol Biol; 1993 Sep; 9(3):323-34. PubMed ID: 8398170
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
[TBL] [Abstract][Full Text] [Related]
9. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
10. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
11. Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization.
Aanaes K; Johansen HK; Poulsen SS; Pressler T; Buchwald C; Høiby N
J Cyst Fibros; 2013 Jan; 12(1):81-7. PubMed ID: 22819141
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies directed against bactericidal/permeability-increasing protein in patients with cystic fibrosis: association with microbial respiratory tract colonization.
Aebi C; Theiler F; Aebischer CC; Schoeni MH
Pediatr Infect Dis J; 2000 Mar; 19(3):207-12. PubMed ID: 10749460
[TBL] [Abstract][Full Text] [Related]
13. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients.
Woods DE; Bass JA; Johanson WG; Straus DC
Infect Immun; 1980 Dec; 30(3):694-9. PubMed ID: 7014444
[TBL] [Abstract][Full Text] [Related]
14. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
15. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
16. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
17. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
18. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
Pier GB; Grout M; Zaidi TS; Goldberg JB
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
[TBL] [Abstract][Full Text] [Related]
19. Prevention of severe lower respiratory infections in patients with cystic fibrosis.
Speert DP
Semin Respir Infect; 1989 Dec; 4(4):266-71. PubMed ID: 2516638
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens.
Biesbrock AR; Reddy MS; Levine MJ
Infect Immun; 1991 Oct; 59(10):3492-7. PubMed ID: 1910004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
